5BVF
Tetrahydropyrrolo-diazepenones as inhibitors of ERK2 kinase
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 5.0.1 |
Synchrotron site | ALS |
Beamline | 5.0.1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2013-11-07 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 1.0 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 44.056, 70.070, 119.407 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 60.433 - 1.900 |
R-factor | 0.1827 |
Rwork | 0.181 |
R-free | 0.22060 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1ERK |
RMSD bond length | 0.008 |
RMSD bond angle | 1.071 |
Data reduction software | PROCESS |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | PHENIX (1.9_1692) |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 60.440 |
High resolution limit [Å] | 1.900 |
Number of reflections | 28614 |
<I/σ(I)> | 19.6 |
Completeness [%] | 95.8 |
Redundancy | 4.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293 | 20mM Mg Sulfate, 20% PEG 3350 |